Kd. Robertson et Pa. Jones, Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus, ONCOGENE, 18(26), 1999, pp. 3810-3820
The INK4a/ARF locus on human chromosome 9p resides at the nexus of two crit
ical cell cycle regulatory pathways, the p53 pathway and the retinoblastoma
(pRb) gene pathway, Through the use of shared coding regions and alternati
ve reading frames two distinct proteins are produced: INK4a is a cyclin-dep
endent kinase inhibitor whereas ARF binds the MDM2 protooncogene and stabil
izes p53. We have examined the expression patterns of the INK4a/ARF locus a
t the RNA level in normal human and murine tissues to determine if these ge
nes are coordinately regulated. We found that both INK4a and ARF were expre
ssed in most tissues at lon levels detectable only by RT-PCR, The pancreas
was an exception in that it expressed no detectable ARF mRNA but expressed
high levels of INK4a mRNA, Furthermore, human pancreas expressed an additio
nal previously unrecognized splice variant of INK4a, termed p12, through th
e use of an alternative splice donor site within intron 1. The p12 transcri
pt produced a 12 kD protein composed of INK4a exon 1 alpha and a novel intr
on-derived C-terminus. This novel protein did not interact with cdk4 but wa
s capable of suppressing growth in a pRb-independent manner. The implicatio
ns of the capacity of the INK4a/ARF locus to encode a third transcript, and
for pancreatic cancer, in which the INK4a/ARF locus is nearly always alter
ed, are considered.